Ask hospital administrators why their supply costs keep climbing and you'll hear the same answer: prices are going up. They're not wrong. But after six years of managing medical supply procurement for a 340-bed regional hospital—signing off on roughly $4.8 million in annual purchases and reviewing thousands of order lines—I've learned that the price tag is rarely the real problem.
Here's what I mean.
Every budget season, finance asks me to squeeze the supply line. And every budget season, someone proposes switching to lower-cost vendors. Sometimes it works. More often than not, it just moves money from a predictable invoice to a less visible line—one that won't get scrutinized until months later.
The $17,000 "Savings" That Cost Us $31,000
Back in early 2023, I was under pressure to cut our supply budget. One of the first categories I looked at was disposable bed pads. We'd been using Medline disposable bed pads for years. They weren't the cheapest option, but I'd never gotten a complaint about them—and in procurement, "no complaints" is a pretty solid endorsement.
Then another brand's quote came in $2.40 per case lower. At our volume—about 7,000 cases a year—that added up to roughly $17,000 in projected savings. Looked like an easy win. I switched us over in March.
By June, our med-surg floors were reporting leaks. Not on every pad, but on enough of them that the laundry volume ticked up and patients with limited mobility needed more frequent changes. A few patients developed skin irritation that required wound care involvement. When I sat down in July and calculated the full cost—extra linen, extra nursing time, extra clinical follow-up—that $17,000 in projected savings had turned into an estimated $31,000 in added cost. We switched back before the end of the year.
Before you write that off as a rookie mistake: I'd been managing this department for four years when I approved that change. And I've watched the same pattern play out in categories far more expensive than bed pads. The price of a product is not its cost. The real cost is hidden in how the product performs in your actual workflow.
What Is Sterile Processing, and Why Should a Buyer Care?
Somewhere along the way, I realized I didn't really understand what clinical staff did with the products I bought. So I started spending time in departments I'd never seen before—including sterile processing.
Honestly, if you'd asked me "What is sterile processing?" a few years ago, I would've said something vague about washing surgical instruments. It's a lot more than that.
Sterile processing is the system that decontaminates, inspects, assembles, packages, sterilizes, and stores reusable surgical instruments. It's the reason a surgeon can open a tray in the OR and trust that everything on it is safe to use. It's also one of the biggest invisible cost centers in a hospital.
Every product decision you make affects that system. If you buy an instrument that doesn't match your sterilizer loading pattern, or a tray that doesn't fit your storage system, sterile processing techs have to adapt. That takes labor. It takes time. It increases the likelihood of error. And unlike the product price, that cost repeats every time the instrument is reprocessed.
Now consider a high-complexity procedure like heart valve replacement. I'm not a clinician, so I won't pretend to walk through the instrument table. But from a procurement standpoint, the math is simple: a delay waiting for a missing or incompatible surgical item costs more than the item itself. OR time is expensive. Finance can give you a number per minute, but it's an average at best—and average or not, a single 15-minute delay can cancel out whatever you "saved" by choosing a cheaper product.
Here's what makes this tricky for someone in my position: none of these costs show up as "product A caused a problem." They show up as overtime, expedited shipping, excess inventory, denial write-offs, or extended lengths of stay. By the time the numbers land on a cost report, the connection to the original purchasing decision is long gone.
Now apply that logic to an item most people never think about until they need it: the manual resuscitator. These are the hand-operated ventilation devices stored on crash carts and in emergency bays. They look similar across brands. They all come in a bag with the same basic design. And the price range is wide enough that "cheaper" can be tempting.
We once had a vendor offer us a significantly better price on manual resuscitators. Our clinical education team pushed back. They periodically test emergency equipment, and they felt the valve response on the discounted units was inconsistent. Not enough to fail a formal check—but enough that experienced nurses didn't want to use them during a code.
I couldn't put a dollar figure on that hesitation. But I knew that if I forced the issue to save maybe $4,000, and a clinician hesitated for even one second during a real resuscitation, the cost could be catastrophic in ways no spreadsheet would ever capture.
We kept the higher-priced units.
Honestly, I can't prove the cheaper units would have failed when it mattered. My best guess is they'd have worked fine most of the time. But "probably fine" isn't the standard for emergency equipment.
That decision looks irrational if you're only comparing purchase prices. It looks perfectly rational if you understand the total cost of failure.
What That Blind Spot Costs
In late 2024, I went back through six years of procurement data and categorized every budget overrun by root cause. I expected price increases to dominate. They didn't.
Roughly 58% of our overruns—I want to say 58%, though I might be misreading my own spreadsheet—traced back to product failures, workflow mismatches, and reorders, not to the price of the products themselves. We were losing more money to the hidden consequences of how we purchased than to inflation.
That's a hard thing to admit, because it means the problem isn't outside our control. It also means the fix isn't "find a cheaper supplier." The fix is to change how we evaluate suppliers in the first place.
Here's how I'd frame it for your own facility. Take any product category you buy, estimate the annual spend, then ask yourself what percentage of that spend disappears into extra handling, reprocessing, or failure. A 5% drag on a $200,000 category is $10,000 a year. A 10% drag on a $1 million category is $100,000. Most facilities never measure it, so they never see it.
The Uncomfortable Fix: Stop Buying on Price
I'm not going to give you a five-step checklist, because that's not how this works. But I can tell you what changed in our purchasing process.
First, we stopped treating unit price as the primary metric. Every major purchase now includes input from the departments that actually use the product. For anything that touches sterile processing, we ask how it fits into our workflow before we talk about price.
Second, we consolidated our vendor list. We used to spread orders across more suppliers than we could reasonably manage. Most of our supply orders now go through a few primary distributors. Medline is one of them—not because they always had the lowest price, but because ordering through the Medline store gave us visibility into our own buying patterns and helped us standardize. When you can see exactly what you're ordering and how often, you stop paying for the same product twice in different packaging.
Third, we started running small pilots before full switches. The bed pad lesson taught me that data from a two-week clinical trial is worth more than a thousand dollars saved on a quote.
The truth is, medical supplies are getting more expensive, and no purchasing manager can reverse that. But the biggest savings aren't hiding in a cheaper quote. They're hiding in the time, labor, and risk created by purchasing decisions that ignore how products actually perform.
Ask yourself what a product costs over a year of real use, not what it costs on the day you buy it. That single question would have saved us over $30,000 in one category alone. It's the least exciting procurement strategy I know. It's also the one that actually worked.
